Evaluation of JAK2V617F in B and T Cell Neoplasms: Identification of JAK2V617F Mutation of Undetermined Significance (JMUS) in the Bone Marrow of Three Individuals

Y.L. Wang,J.W. Lee,J.S. Kui,Amy Chadburn,Nicholas C.P. Cross,Daniel M. Knowles,Morton Coleman

Evaluation of JAK2V617F in B and T Cell Neoplasms: Identification of JAK2V617F Mutation of Undetermined Significance (JMUS) in the Bone Marrow of Three Individuals

2007

Y.L. Wang
J.W. Lee
J.S. Kui
Amy Chadburn
Nicholas C.P. Cross
Daniel M. Knowles
Morton Coleman

Background/Aims: The JAK2 V617F mutation, which has been found in patients with myeloproliferative disorders (MPD), has not yet been evaluated in lympho

Keywords:

Diabetes mellitus
Immunology
Bone marrow
Medicine
Myeloproliferative Disorders
Mutation
T cell
Monoclonal gammopathy of undetermined significance
Multiple myeloma
B cell
Pathology
in patient
JAK2 V617F

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations